Journals / Türk Nöroloji Dergisi / 2020 / Cilt: 26 - Sayı: 2

Acquired Immune Deficiency Syndrome Showing Its First Symptom with Nervous System Involvement

İlk Semptomunu Sinir Sistemi Tutulumu ile Gösteren Edinilmiş Bağışıklık Yetmezliği Sendromu

Pages
165–172
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this article was to present patients who were admitted to Pamukkale University Hospital, Neurology Clinic with neurologic symptoms as the first clinical evidence of HIV infection, and to compare their patterns of neurologic involvement with patterns in the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Human immunodeficiency virus (HIV) infection is increasingly common today and the diversity of its clinical presentation makes the diagnosis difficult.
📊
Key Findings & Data:The virus can cause neurologic involvement in the entire nervous system through direct action or opportunistic infections.
💡
Conclusion & Impact:The aim of this article was to present patients who were admitted to Pamukkale University Hospital, Neurology Clinic with neurologic symptoms as the first clinical evidence of HIV infection, and to compare their patterns of neurologic involvement with patterns in the literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Human immunodeficiency virus (HIV) infection is increasingly common today and the diversity of its clinical presentation makes the diagnosis difficult. The virus can cause neurologic involvement in the entire nervous system through direct action or opportunistic infections. HIV-associated neurocognitive disease, HIV encephalopathy, HIV-associated vacuolar myelopathy, and distal symmetric polyneuropathy are some of the neurologic involvements. The aim of this article was to present patients who were admitted to Pamukkale University Hospital, Neurology Clinic with neurologic symptoms as the first clinical evidence of HIV infection, and to compare their patterns of neurologic involvement with patterns in the literature.

Özet

İnsan immün yetmezlik virüsü (HIV) enfeksiyonu günümüzde artan sıklıkla görülmekte ve klinik prezentasyon çeşitliliği tanıyı güçleştirmektedir. Virüs direktetki veya fırsatçı enfeksiyonlar yolu ile tüm sinir sisteminde nörolojik tutulum yapabilmektedir. HIV ilişkili nörokognitif hastalık, HIV ensefalopatisi, HIVilişkili vakuoler miyelopati ve distal simetrik polinöropati nörolojik tutuluma bağlı tablolardan bazılarıdır. Bu makalede, Pamukkale Üniversitesi Hastanesi,Nöroloji Kliniği’ne başvuran, ilk semptomlarını nörolojik sistem tutulumu ile gösteren ve HIV tanısı alan hastaların sunulması ve nörolojik tutulum özelliklerinindetaylandırılarak, literatür ile karşılaştırılması amaçlanmıştır.

🔖

Cite This Article

DEĞİRMENCİ, E., KUTLU, S. S., ÜNLÜTÜRK, Z. (2022). Acquired Immune Deficiency Syndrome Showing Its First Symptom with Nervous System Involvement. Türk Nöroloji Dergisi, Cilt: 26 - Sayı: 2, 165–172. https://ajindex.com/articles/636683

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Siddiqi OK, Agnihotri S, Koralnik IJ. Neurologic diseases caused by human immunodeficiency virus type 1 and opportunistic infections. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases 2014:1690-1706
  2. Góngora-Rivera F, Santos-Zambrano J, Moreno-Andra de T, Calza daLópez P, SotoHernández JL. The clinical spectrum of neurological manifestations in AIDS patients inMexico. Arch Med Res 2000;31:393-398
  3. Wojna V, Skolasky RL, Hechavarria R, et al. Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J Neurovirol 2006;12:356-364
  4. Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ, National HIV Survelillance Committee. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 2003;17:1539-1545
  5. Budka H. Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis. Acta Neuropathol Berl 1989;77:225-236
  6. Portegies P, Enting RH, de Gans J, et al. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands. AIDS 1993;7:66-675
  7. Simpson DM, Berger JR. Neurologic manifestations of HIV infection. Med Clin North Am 1996;80:1363-1394
  8. McArthur JC, Brew BJ, Nath A. Neurological complications of HIV infection. Lancet Neurol 2005;4:543-555
  9. Ntshangase S, Mdanda S, Naicker T, Kruger HG, Govender T, Baijnath S. Rilpivirine as a potential candidate for the treatment of HIV-associated neurocognitive disorders (HAND). Journal of Molecular Histology 2019;50:295-303
  10. Levy RM, Mills CM, Posin JP, Moore SG, Rosenblum ML, Bredesen DE. The efficacy and clinical impact of brain imaging in neurologically symptomatic AIDS patients: a prospective CT/MRI study. J Acquir Immune Defic Syndr 1990;3:461-471
  11. Guideline for the prevention and treatment of opportunistic infections in HIV-Infected Adults and Adolescents. 2016. Available from: URL: https:// aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf 12. Torre D, Casari S, Speranza F, et al. Randomized trial of trimethoprimsulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Antimicrob Agents Chemother 1998;42:1346-1349
  12. Duval X, Pajot O, Le Moing V, et al. Maintenance therapy with cotrimoxazole for toxoplasmic encephalitis in the era of highly active antiretroviral